McKesson Corporation (MCK) Earnings Call Analysis

NYSE · Healthcare · Medical Distribution

24/25

Growth 5 Margin 4 Expansion 5 Platform 5 Financial 5

latest quarter score

Earnings Reports

24
McKesson (MCK) Q1 2027: Oncology and Multispecialty Revenue Jumps 33%, Accelerating Specialty Platform Leverage
August 06, 2026
25
McKesson (MCK) Q3 2026: Oncology and Biopharma Drive 37% Segment Surge, Portfolio Realignment Accelerates
June 15, 2026
25
McKesson (MCK) Q4 2026: Oncology and Multi-Specialty Profit Jumps 53% as Platform Scale Accelerates
May 08, 2026
25
McKesson (MCK) Q2 2026: Oncology and Multispecialty Profit Surges 71% as Platform Expansion Accelerates
November 06, 2025
20
McKesson (MCK) Q1 2026: Specialty Pharma and GLP-1 Drive 25% U.S. Revenue Surge
August 06, 2025
25
McKesson (MCK) Q4 2025: Oncology Platform Adds 725 Providers, Driving Strategic Margin Expansion
June 30, 2025

Browse all companies